Alzheimer's disease clinical trials success rate globally from 2008-2019, by phase

Published by
Matej Mikulic,
Jun 3, 2022
This statistic depicts the success rate of Alzheimer's disease clinical trials globally, compared to other drugs, from 2008 to 2019, by phase. During that time, 57 percent of trials for all diseases were successful in phase III, while none of the Alzheimer's disease clinical trials were successful during phase III.

Probability of success for Alzheimer's drug clinical trials worldwide from 2008 to 2019, by phase

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

May 2019

Region

Worldwide

Survey time period

Data from January 2008 to February 2019

Supplementary notes

Data for Alzheimer’s Disease is based on approximately 139 drug program transitions in the Biomedtracker database.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Dementia and Alzheimer's disease in Europe "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Dementia and Alzheimer's disease in Europe

World overview

6

European focus

5

Mortality and morbidity

8

Situation in specific countries

8

Policies directed towards dementia

8

Further related statistics

20

Further Content: You might find this interesting as well

Statistics

Topics

Dementia and Alzheimer's disease in EuropeDementia and Alzheimer's disease in the United StatesLong-term care in the U.S.Mental health in Europe
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.